Summary
The role of prognostic factors in optimizing treatment for breast cancer patients has clearly changed with the trend toward general use of adjuvant therapy. Nevertheless, there are at least three situations in which prognostic factors could be helpful. The first is to identify patients whose prognosis is so good that adjuvant therapy after local surgery would not be cost-beneficial. The second is to identify patients whose prognosis is so poor that a more aggressive adjuvant approach would be warranted. The third is to identify patients likely to be responsive or resistant to particular forms of therapy. Here we will discuss all of these situations, together with the appropriate cutpoint analyses and validation of individual prognostic factors and their combination into prognostic indexes which may make the discrimination of patient subsets more reliable.
Similar content being viewed by others
References
Early Breast Cancer Trialists' Collaborative Group: Systemic treatment of early breast cancer by hormonal, cytotoxic, or immune therapy. Lancet 339:1–15,71-85, 1992.
Anonymous: NIH Consensus Conference. Treatment of early-stage breast cancer. J Am Med Assoc 265: 391-395, 1991.
Carter CL, Allen C, Henson DE: Relation of tumor size, lymph node status, and survival in 24,740 breast cancer cases. Cancer 63:181–187, 1989.
Rosen PP, Groshen S, Kinne DW: Prognosis in T2M0N0 stage I breast carcinoma: a 20-year follow-up study. J Clin Oncol 9:1650–1661, 1991.
Tabar L, Fagerberg G, Day NE, et al: Breast cancer treatment and natural history: new insights from results of screening. Lancet 339:412–414, 1992.
McGuire WL, Clark GM: Prognostic factors and treatment decisions in node-negative breast cancer. N Engl J Med 326:1756–1761, 1992.
Haybittle JL, Blamey RW, Elston CW, et al: A prognostic index in primary breast cancer. Br J Cancer 45: 361–366, 1982.
Galea MH, Blamey RW, Elston CW, Ellis IO: The Nottingham Prognostic Index in primary breast cancer. Breast Cancer Res Treat 22:207–219, 1992.
Hilsenbeck SG, Clark GM, McGuire WL: Why do so many prognostic factors fail to pan out? Breast Cancer Res Treat 22:197–206, 1992.
Ciocca DR, Tandon AK, Fuqua SAW, et al: Heat shock protein hsp70 with axillary lymph node-negative breast cancer patients: prognostic implications. J Natl Cancer Inst 85:570–574, 1993.
Ravdin PM: Evaluation of cathepsin D as a prognostic factor in breast cancer. Breast Cancer Res Treat 24: 219–226, 1993.
Osborne CK: Prognostic factors for breast cancer: have they met their promise? J Clin Oncol 10:679–682, 1992.
Clark GM, Wenger CR, Beardslee S, et al: How to integrate steroid hormone receptor, flow cytometric, and other prognostic information in regard to primary breast cancer. Cancer 71:2157–2162, 1993.
Slamon DJ, Clark GM, Wong SG, et al: Human breast cancer: correlation of relapse and survival with amplification of the HER-2/neu oncogene. Science 235:177–182, 1987.
Clark GM, McGuire WL: Follow-up study of HER-2/neu amplification in primary breast cancer. Cancer Res 51:944–948, 1991.
Allred DC, Clark GM, Tandon AK, et al: HER-2/neu in node-negative breast cancer. Prognostic significance of overexpression influenced by presence of in situ carcinoma. J Clin Oncol 10:599–605, 1992.
Gusterson BA, Gelber RD, Goldhirsch A, et al: Prognostic importance of c-erbB-2 expression in breast cancer. J Clin Oncol 10:1049–1056, 1992.
Muss H, Thor A, Kute T, et al: erbB-2 (c-cerbB-2; HER-2/neu) and S-phase fraction predict response to adjuvant chemotherapy in patients with node-positive breast cancer: Cancer and Acute Leukemia Group B Trial 8869. Proc ASCO 12:72, 1993.
Ciocca DR, Fuqua SAW, Lock-Lim S, et al: Response of human breast cancer cells to heat shock and chemotherapeutic drugs. Cancer Res 52:3648–3654, 1992.
Oesterreich S, Weng C-N, Qiu M, et al: The small heat shock protein hsp27 is correlated with growth and drug resistance in human breast cancer cell lines. Cancer Res, in press.
Author information
Authors and Affiliations
Rights and permissions
About this article
Cite this article
Clark, G.M. Do we really need prognostic factors for breast cancer?. Breast Cancer Res Tr 30, 117–126 (1994). https://doi.org/10.1007/BF00666054
Issue Date:
DOI: https://doi.org/10.1007/BF00666054